ALEKSANDR SHOYKHET: Open Payments
NPI 1407263494 · FLORISSANT, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,380 in 38 payments from 14 companies in 2025. Trend: 2023 $3,772 · 2024 $1,154 · 2025 $2,380
Food & beverage: $1,271Travel & lodging: $1,109
| Company | Payments | Amount |
|---|---|---|
| MML US, Inc. | 3 | $1,227 |
| Medtronic, Inc. | 16 | $397 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 2 | $244 |
| Vanda Pharmaceuticals Inc. | 1 | $125 |
| ACADIA Pharmaceuticals Inc | 1 | $117 |
| Azurity Pharmaceuticals, Inc. | 3 | $49 |
| VERTEX PHARMACEUTICALS INCORPORATED | 3 | $45 |
| PROTEGA PHARMACEUTIALS INC | 2 | $38 |
| Valinor Pharma, LLC | 2 | $33 |
| TerSera Therapeutics LLC | 1 | $25 |
Products named: ReActiv8, RELISTOR, FANAPT, INCEPTIV, NUPLAZID, INTELLIS ADAPTIVESTIM, SYNCHROMEDII, KYPHON EXPRESS II KYPHOPAK TRAY.
Industry payments across MO — which companies pay providers there.
